Barthelemy Nicolas
Director at RGEN; VP, Corporate Development at MASS; Director at TWST, and 2 more
- Sold, on record
- $16.3M
- Dollars the filings state
- Form 4 sales
- 34
- Latest Oct 29, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 5
- Filed as an executive or holder
Companies
- RGENREPLIGEN CORPDirector
- MASS908 Devices Inc.VP, Corporate Development
- TWSTTwist Bioscience CorpDirector
- LABSTANDARD BIOTOOLS INC.Director
- INVITROGEN CORPPres, Commercial Operations
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- INVITROGEN CORP182,408 shares
- RGEN44,324 shares
- MASS13,000 shares
- LAB5,100 shares
- TWST5,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LABPlan not statedJun 17 2019
Sold 5,100 shares at $12.43 ($63k)
Barthelemy Nicolas, Director
Sold 10.9% of holdings ($584k position)41,849 shares leftFirst sale on recordFiling
- 2 Form 4 sale RGENUnusualApr 3 +291 days
Sold 2,688 shares at $99.99 ($269k)
Barthelemy Nicolas, Director
Sold 39.8% of holdings ($676k position)4,073 shares leftFiling
- 3 Form 4 sale RGENUnusualApr 22 +19 days
Sold 2,688 shares at $109.99 ($296k)
Barthelemy Nicolas, Director
Sold 47% of holdings ($630k position)3,037 shares left0.4x usual sizeFiling
- 4 Form 4 sale RGENUnusualMay 18 +26 days
Sold 3,009 shares at $142.53 ($429k)
Barthelemy Nicolas, Director
Sold 53% of holdings ($809k position)2,664 shares left1.1x usual sizeFiling
- 5 Form 4 sale RGENUnusualNov 9 +175 days
Sold 1,214 shares at $195.51 ($237k)
Barthelemy Nicolas, Director
Sold 45.6% of holdings ($521k position)1,450 shares left0.5x usual sizeFiling
- 6 Form 4 sale TWSTUnusualFeb 9 +92 days
Sold 5,000 shares at $177.61 ($888k)
Barthelemy Nicolas, Director
Sold 72.5% of holdings ($1.2M position)1,898 shares leftFirst sale on recordFiling
- 7 Form 4 sale MASSUnusualJun 24 +135 days
Sold 13,000 shares at $39.72 ($516k)
Barthelemy Nicolas, VP, Corporate Development
Sold 49% of holdings ($1.1M position)13,541 shares leftFirst sale on recordFiling
- 8 Form 4 sale RGENUnusualOct 29 +127 days
Sold 1,645 shares at $288.20 ($474k)
Barthelemy Nicolas, Director
Sold 51.5% of holdings ($920k position)1,547 shares left0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (34)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2021 | RGEN | Director | Form 4 sale | 1,645 | $474k | 51.5% | Unusual | SEC |
| Jun 24, 2021 | MASS | VP, Corporate Development | Form 4 sale | 13,000 | $516k | 49.0% | Unusual | SEC |
| Feb 9, 2021 | TWST | Director | Form 4 sale | 5,000 | $888k | 72.5% | Unusual | SEC |
| Nov 9, 2020 | RGEN | Director | Form 4 sale | 1,214 | $237k | 45.6% | Unusual | SEC |
| May 18, 2020 | RGEN | Director | Form 4 sale | 3,009 | $429k | 53.0% | Unusual | SEC |
| Apr 22, 2020 | RGEN | Director | Form 4 sale | 2,688 | $296k | 47.0% | Unusual | SEC |
| Apr 3, 2020 | RGEN | Director | Form 4 sale | 2,688 | $269k | 39.8% | Unusual | SEC |
| Jun 17, 2019 | LAB | Director | Form 4 sale | 5,100 | $63k | 10.9% | Plan not stated | SEC |
| Aug 29, 2018 | RGEN | Director | Form 4 sale | 6,580 | $358k | 61.1% | Unusual | SEC |
| May 9, 2018 | RGEN | Director | Form 4 sale | 26,500 | $1.1M | 84.5% | Unusual | SEC |
| Dec 10, 2010 | INVITROGEN CORP | Pres, Commercial Operations | Form 4 sale | 31,208 | $1.6M | 75.9% | Unusual | SEC |
| Apr 29, 2010 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 14,781 | $813k | 31.3% | Unusual | SEC |
| Mar 16, 2010 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 17,132 | $908k | 34.4% | Unusual | SEC |
| Mar 2, 2010 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 1,603 | $82k | 4.7% | Plan not stated | SEC |
| Dec 15, 2009 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 5,300 | $276k | 16.5% | Plan not stated | SEC |
| Nov 23, 2009 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 15,000 | $749k | 31.9% | Unusual | SEC |
| Nov 16, 2009 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 5,000 | $252k | 13.5% | Plan not stated | SEC |
| Jul 30, 2009 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 6,500 | $306k | 14.9% | Plan not stated | SEC |
| Jun 2, 2009 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 3,000 | $120k | 7.5% | Plan not stated | SEC |
| May 13, 2009 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 4,626 | $169k | 10.3% | Plan not stated | SEC |
| May 1, 2009 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 352 | $13k | 0.9% | Plan not stated | SEC |
| Apr 29, 2009 | INVITROGEN CORP | President, Cell Systems | Form 4 sale | 7,084 | $253k | 15.1% | Plan not stated | SEC |
| Apr 23, 2008 | INVITROGEN CORP | SVP, Cell Culture Systems | Form 4 sale | 2,500 | $233k | 17.4% | Plan not stated | SEC |
| Mar 27, 2008 | INVITROGEN CORP | SVP, Cell Culture Systems | Form 4 sale | 2,500 | $214k | 17.4% | Plan not stated | SEC |
| Nov 26, 2007 | INVITROGEN CORP | SVP, Cell Culture Systems | Form 4 sale | 13,579 | $1.3M | 53.3% | Unusual | SEC |
| Nov 15, 2007 | INVITROGEN CORP | SVP, Cell Culture Systems | Form 4 sale | 3,531 | $318k | 22.9% | Plan not stated | SEC |
| Nov 12, 2007 | INVITROGEN CORP | SVP, Cell Culture Systems | Form 4 sale | 3,250 | $293k | 21.4% | Plan not stated | SEC |
| Oct 31, 2007 | INVITROGEN CORP | SVP, Cell Culture Systems | Form 4 sale | 22,268 | $2M | 65.2% | Unusual | SEC |
| Oct 18, 2007 | INVITROGEN CORP | SVP, Cell Culture Systems | Form 4 sale | 5,640 | $477k | 100.0% | Unusual | SEC |
| Jul 10, 2007 | INVITROGEN CORP | SVP, Cell Culture Systems | Form 4 sale | 7,250 | $544k | 100.0% | Unusual | SEC |
| Jun 15, 2007 | INVITROGEN CORP | SVP, Cell Culture Systems | Form 4 sale | 3,250 | $244k | 26.4% | Unusual | SEC |
| Jun 11, 2007 | INVITROGEN CORP | SVP, Cell Culture Systems | Form 4 sale | 437 | $32k | 100.0% | Unusual | SEC |
| May 15, 2007 | INVITROGEN CORP | SVP Cell Culture Systems | Form 4 sale | 1,617 | $116k | 17.6% | Plan not stated | SEC |
| Mar 13, 2006 | INVITROGEN CORP | Svp | Form 4 sale | 5,000 | $349k | 46.9% | Unusual | SEC |